← Eichor
Study identifier: NCT07095894 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

Condition: Myopia  ·  Sponsor: Jaeb Center for Health Research

PhasePhase 3
Planned participants348
Who can joinAll sexes, 5 Years to 11 Years
Healthy volunteersNo

About this study

To date, randomized trials of low-concentration atropine eyedrops and specially designed spectacle lenses to slow the progression of myopia are limited in number and results are inconsistent in non-Asian children. Although results of some recent randomized clinical trials outside the US are promising, additional studies in children are needed to test the safety and efficacy of low-concentration atropine and specially designed spectacle lenses as treatments to slow the progression of myopia during the peak years for eye growth. After a run-in phase to demonstrate adherence with nightly eyedrops (artificial tears) and spectacle correction, children 5 to \<12 years old with myopia of 0.75D to 6.00D cycloplegic spherical equivalent refractive error (SER) and at least 0.75D myopia in both principal meridians of each eye will be randomized in a 2x2 factorial design to treatment with 1) nightly 0.05% atropine or placebo eyedrops, and 2) spectacles with highly aspherical lenslet target (H.A.L.T.) MAX technology or single vision spectacles, and followed every six months for 24 months. Change in axial length over 24 months and change in SER over 24 months are the primary and secondary outcomes, respectively. All children will return for a visit at 30 months (after 6 months of no treatment other than single-vision spectacles alone between 24 and 30 months). The study is funded by the National Eye Institute, part of the NIH, and coordinated by the Jaeb Center for Health Research on b…

This description comes directly from the study's public registry record.

Talk to the study team

Raymond T Kraker, MSPH  ·  813-975-8690  ·  rkraker@jaeb.org

Courtney L Conner  ·  813-975-8690  ·  cconner@jaeb.org

Always discuss trial participation with your own doctor first.

Locations (17)

UAB Pediatric Eye Care; Birmingham Health CareBirmingham, Alabama, United StatesRecruiting
University of ArizonaTucson, Arizona, United StatesRecruiting
Marshall B. Ketchum UniversityFullerton, California, United StatesRecruiting
Stanford UniversityPalo Alto, California, United StatesRecruiting
Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Illinois, United StatesRecruiting
Illinois College of OptometryChicago, Illinois, United StatesRecruiting
Boston Children's Hospital WalthamBoston, Massachusetts, United StatesRecruiting
Corewell HealthGrand Rapids, Michigan, United StatesRecruiting
Duke University Eye CenterDurham, North Carolina, United StatesRecruiting
Pediatric Ophthalmology Associates, Inc.Columbus, Ohio, United StatesRecruiting
Ohio State University College of OptometryColumbus, Ohio, United StatesRecruiting
Casey Eye InstitutePortland, Oregon, United StatesRecruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07095894